← Back to catalogue
Leukocyte Reduction Filters (sets)
EUDAMEDClass IIb (EU MDR)
Ref FBRC450-HE10Model FBPL01K-HE10, FBPL01K-HE10, FBPL01K-HX11, FBRC100-HE10, FBRC100-HE11, FBRC100-HX10, FBRC100-HX11, FBPL01K-HE11, FBRC200-HE10, FBRC200-HE11, FBRC200-HX10, FBRC200-HX11, FBRC400-HE10, FBRC400-HE11, FBRC400-HX10, FBRC400-HX11, FBRC450-HE10, FBRC450-HE11
Identity
- Device Name
- Leukocyte Reduction Filters (sets) EUDAMED
- Model / Reference
- FBPL01K-HE10, FBPL01K-HE10, FBPL01K-HX11, FBRC100-HE10, FBRC100-HE11, FBRC100-HX10, FBRC100-HX11, FBPL01K-HE11, FBRC200-HE10, FBRC200-HE11, FBRC200-HX10, FBRC200-HX11, FBRC400-HE10, FBRC400-HE11, FBRC400-HX10, FBRC400-HX11, FBRC450-HE10, FBRC450-HE11 EUDAMEDFBRC450-HE10 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 06971942261092 EUDAMED
- Basic UDI-DI
- 697194226FBGRL EUDAMED
- EMDN Code
- B02010201 LABORATORY ERYTHROCYTES (RBC) LEUKOREDUCTION FILTERS EUDAMED
Classification
- Device Class
- Class IIb EUDAMED
- Market of Registration
- Germany EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Leukocyte Reduction Filters (sets) by Guangzhou DaJi Medical Science and Technology Co., Ltd. — Class IIb — MDR — listed in EUDAMED
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 697194226FBGRL | Class IIb | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- EUDAMED SRN
- CN-MF-000035091
- Authorised Representative
- Share info GmbH DE-AR-000005132
Sources (1)
- EUDAMED adebeed1-53ef-45d6-99da-f653c7416b7c 61 fields · synced Oct 8, 2026